chevron_leftBack
As of 7 June 2026, China Health Group Inc. has a market cap of $17.15M USD, ranking #38164 globally and #6308 in China.
It ranks #3406 in the Healthcare sector, and #216 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$17.15MUSD
134.37M HKD
Enterprise Value
$13.72MUSD
107.47M HKD
Revenue (TTM)
$4.06MUSD
31.79M HKD
EBITDA (TTM)
-$2.06MUSD
-16.18M HKD
Net Income (TTM)
-$2.13MUSD
-16.65M HKD
EBITDA Margin
-51%
Profit Margin
-52%
PS Ratio
4.2
PB Ratio
2.2
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.5% | -0.7% | 6.3% | -5.6% | -17% | -10% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
8225
中国医疗集团有限公司
ISIN: KYG2117N1088
Shares Out.:
Shares Outstanding:
995.352M1
Shares Float:
298.246M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.1350 HKD | |
|
VNL1
中国医疗集团有限公司
ISIN: KYG2117N1088
|
0.0050 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About China Health Group Inc.
China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers pharmacodynamics and clinical research of drugs. China Health Group Inc. was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. The company was founded in 1998 and is headquartered in Beijing, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SHE: 002001
|
$15.86B
92K%
107.34B CNY
|
16.0
|
|
SHE: 002653
|
$9.1B
53K%
61.6B CNY
|
80.6
|
|
SHE: 000423
|
$5.22B
30K%
35.33B CNY
|
20.0
|
|
SHE: 002603
|
$4.21B
24K%
28.47B CNY
|
20.8
|
|
SHE: 000623
|
$3.27B
19K%
22.12B CNY
|
8.1
|
|
|
$2.74B
16K%
18.55B CNY
|
11.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.66B
220K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
172K%
|
-
|
|
NSE: CIPLA
|
$11.12B
65K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.0B
64K%
1.05T INR
|
22.7
|
|
EPA: ABVX
|
$8.79B
51K%
7.57B EUR
|
-
|
|
NSE: AUROPHARMA
|
$8.43B
49K%
807.02B INR
|
23.1
|
chevron_leftBack